Apothic Wines, known for their bold, intense blended wines that combine Old World intrigue with New World sophistication, is excited to announce the return of Apothic Dark. Its secret blend highlights unique and uncommon grapes to create a mysterious wine that is evocative of the romance found in darkness. This red wine blends dark fruit flavors of blueberry and blackberry with opulent notes of coffee and dark chocolate for a rich, yet silky smooth, wine experience.
To celebrate the return of Apothic Dark, Apothic Wine is convincing the world to “Go Dark” with its #GoDark campaign. The #GoDark promotion kicked off on September 24 when an impromptu dark parade descended on downtown Austin. Onlookers helping to “Keep Austin Dark” joined more than 50 mysteriously cloaked performance artists and Apothic enthusiasts in a procession that originated from Congress Bridge and culminated with dark revelry at a historic downtown theater.
To view the multimedia release go to:
http://www.multivu.com/players/English/7617151-apothic-wine-godark/
Today, Mark I Love SPAM Benson – who last year legally changed his name as a declaration of his love for the brand - wed his fiancée, Anne Mousley, marking the first wedding to be performed at the world-famous SPAM® Museum. The newlyweds, who hail from Liverpool, U.K., made the journey to Austin, Minn., to say their vows in the one-of-a kind setting adorned with iconic brand memorabilia.
“I am beyond appreciative of my fiancée for making my dream come true, and of the SPAM® Museum for hosting a wedding day that exceeded anything I could have imagined and that I will cherish forever,” said Benson. “Marrying Anne was amazing alone, and the icing on the cake was getting to say our vows at a place dedicated to the brand that I love and holds so much nostalgia for me.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8071051-spam-wedding/
University of St. Augustine for Health Sciences (USAHS), a leading graduate institution that emphasizes health and rehabilitative sciences education through innovative classroom education, is pleased to announce the installation of SafeGait 360° Balance and Mobility Trainer® on its Austin, Texas campus. The device, which was designed in collaboration with experts in physical therapy (PT) and occupational therapy (OT), works to mitigate the risk of injury from falls, protecting both the patient and therapist. In addition, SafeGait 360°’s dynamic fall protection (DFP) distinguishes between a patient’s intentional downward movement and when a patient is actually falling, which allows therapists to easily modify fall protection sensitivity to accommodate and challenge patients at varying stages of independence.
USAHS is one of the first higher education institutions in the nation to install this innovative body-weight support and fall protection system. In addition to conducting ground breaking research with patients and students, faculty members with extensive experience in body-weight treatments aim to open a clinic which will provide new treatment options to patients in the Austin community, and will begin seeing patients in October of this year.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743851-usahs-safegait-360-physical-therapy/
Results from two national surveys of patients receiving chemotherapy and pharmacists, conducted by the Hematology/Oncology Pharmacy Association (HOPA) in collaboration with Eisai Inc.,* found that 83% of patients receiving chemotherapy who have experienced chemotherapy-induced nausea and vomiting (CINV) believe it is a side effect with which they must live. Results also showed that 95% of cancer patients surveyed believe that CINV has, at some point, had an impact on their daily lives. These national surveys are part of the Time to Talk CINV™ campaign, which aims to increase awareness among patients and caregivers about CINV prevention and the importance of speaking with their pharmacist and full healthcare team about this often preventable side effect.
“The survey results underscore the confusion patients who are undergoing chemotherapy have about CINV and the need for them to understand that there are ways to manage their symptoms so that they do not have to needlessly suffer with CINV,” said Scott Soefje, PharmD, MBA, BCOP, President, Hematology/Oncology Pharmacy Association (HOPA) and Director of Pharmacy at the University Medical Center Brackenridge in Austin, TX. “It is imperative that patients discuss CINV prevention early in treatment and with all members of the health care team, including pharmacists.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7560331-time-to-talk-cinv/
